This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
OK

Shedding Light on Neural Stimulation

Taking advantage of optoelectronics, we aim to develop personalized neural stimulation systems.

Learn more about us

Innovative solutions

naos

Synergia Medical is pioneering optoelectronics for neural stimulation therapies by developing an innovative, powerful and versatile neural stimulation technological platform.

By doing so, Synergia Medical will improve patients’ quality of life and pave the way to new personalized therapies.

 

Full range of applications

Synergia Medical’s technology could benefit numerous neurological diseases such as chronic pain, Parkinson’s disease, drug-resistant epilepsy, sleep apnoea and depression.

Synergia Medical’s current IP portfolio includes non-metallic encapsulation of neurostimulators, fast-charging wireless system, a custom optical lead, miniaturized photovoltaic cells and an enhanced electrode.

Drug Resistant Epilepsy Therapy

SYNERGIA MEDICAL OBTAINS BELGIUM HEALTH AUTHORITY APPROVAL TO START FIRST IN HUMAN CLINICAL STUDY

Learn more

SYNERGIA MEDICAL WINS PRESTIGIOUS PRIX GALIEN IN BELGIUM FOR ITS OPTOELECTRONIC NEUROSTIMULATOR

Synergia Medical is pleased to announce that they have been awarded the Prix Galien 2023 in Belgium for promising medical devices.

Learn more

SYNERGIA MEDICAL INCREASES SERIES B FUNDING TO €12.8 MILLION WITH AN ADDITIONAL €3.8 MILLION

Synergia Medical today announced the successful completion of an additional €3.8 million of Series B funding bringing the total to €12.8 million. This allows Synergia Medical to prepare for First-In-Human clinical trials planned for 2024. 

Learn more